financetom
Business
financetom
/
Business
/
Rtx Insider Sold Shares Worth $15,880,937, According to a Recent SEC Filing
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Rtx Insider Sold Shares Worth $15,880,937, According to a Recent SEC Filing
Aug 1, 2024 2:46 PM

05:18 PM EDT, 08/01/2024 (MT Newswires) -- Gregory Hayes, Director, Executive Chairman, on July 31, 2024, sold 134,887 shares in Rtx (RTX) for $15,880,937. Following the Form 4 filing with the SEC, Hayes has control over a total of 584,356 shares of the company, with 566,723 shares held directly and 17,633 controlled indirectly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/101829/000122520824007776/xslF345X03/doc4.xml

Price: 116.51, Change: -0.23, Percent Change: -0.20

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
China's Nio launches Onvo brand to challenge Tesla's best-selling model
China's Nio launches Onvo brand to challenge Tesla's best-selling model
May 15, 2024
SHANGHAI, May 15 (Reuters) - Chinese electric vehicle maker Nio on Wednesday launched the first vehicle under its new brand Onvo to be priced at a lower range and which aims to compete with Tesla's Model Y, the world's best-selling EV. Nio chief executive William Li launched the Onvo L60 SUV in Shanghai, saying the company aimed to take on...
Goldman Sachs hires from rivals to expand in mid-market deals
Goldman Sachs hires from rivals to expand in mid-market deals
May 15, 2024
NEW YORK, May 15 (Reuters) - Goldman Sachs ( GS ) told Reuters it has hired two investment bankers, Kerry Burke and Eddie Rubin, from Evercore ( EVR ) and Lazard ( LAZ ), respectively, as part of a push to double down on its business that focuses on advising on deals worth up to $2 billion. Best known for...
Immutep Says Safety Lead-in Phase of Breast Cancer Study Yields 'Encouraging' Data
Immutep Says Safety Lead-in Phase of Breast Cancer Study Yields 'Encouraging' Data
May 15, 2024
09:02 AM EDT, 05/15/2024 (MT Newswires) -- Immutep ( IMMP ) said Wednesday that the safety lead-in phase of the phase 2/3 trial of a breast cancer therapy yielded encouraging efficacy, safety and pharmacodynamic data. The lead-in showed that the first-ever 90 mg dosing of eftilagimod alpha in combination with weekly paclitaxel remains well-tolerated with a favorable safety profile, the...
Walgreens to Sell Over-the-Counter Naloxone Anti-Narcotic Spray to Reverse Opioid Overdoses
Walgreens to Sell Over-the-Counter Naloxone Anti-Narcotic Spray to Reverse Opioid Overdoses
May 15, 2024
09:01 AM EDT, 05/15/2024 (MT Newswires) -- Walgreens Boots Alliance ( WBA ) said Wednesday it will begin selling emergency opioid overdose medicine over-the-counter. Walgreens Brand Naloxone HCI Nasal Spray will retail for about $35 and can reverse heroin, fentanyl, or prescription opioid overdoses. The drug is already available online and will be stocked in its stores' pain medication aisles...
Copyright 2023-2026 - www.financetom.com All Rights Reserved